May 16th, 2025
Description
This hybrid event is back by popular demand and provides a neuropharmacology update by APPS for APPs. Prior events have hosted over 500 registrants including 31 states and 8 countries! This year’s event will host APP experts in neurology who will provide pharmacologic updates on epilepsy, psychiatric conditions, neurologic emergencies, migraine management, movement disorders, and multiple sclerosis.
Dates and Times
Start: 5/16/2025 8:00 AM
End: 5/16/2025 4:15 PM
Objectives
- Differentiate at least one headache type that is consistent with migraine and one type that is not.
- Identify at least one evidence-based pharmacological treatment option for the acute treatment and prevention of migraine.
- Describe at least one criteria for DMT selection.
- Describe the basic mechanism of action for DMT in MS.
- Describe at least one goal of standard surveillance during DMT.
- Explain at least two common side effects of psychiatric medications and how to manage them.
- Explain at least two ways in which common psychiatric medications impact brain chemistry.
- Describe the mechanism of action of common anti-seizure medications (ASM).
- Identify at least two innovative ASM and a related clinical pearl.
- Identify at least one ASM for patients with epilepsy who have other co-morbid conditions impacting their treatment.
- Identify at least two categories of medications used in the treatment of Parkinson's Disease (PD).
- Identify at least one medication for targeted symptomatic treatment in PD.
- Describe at least one pharmacological consideration in the early, mid and late stages of PD
- Discuss at least two interventions for status epilepticus.
- Discuss blood pressure parameters for patients with neurologic injuries.
- Describe at least one pharmacologic intervention in acute herniation syndromes.
Location
Fawcett Center
2400 Olentangy River Rd.
Columbus, OH 43202
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
, the faculty, the planners, the reviewers, and the CME provider have no relevant financial relationship with a commercial interest (defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients), that relates to the content that will be discussed in the educational activity.